SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

AC Immune SA – ‘6-K’ for 3/30/20

On:  Monday, 3/30/20, at 9:08am ET   ·   For:  3/30/20   ·   Accession #:  950103-20-6220   ·   File #:  1-37891

Previous ‘6-K’:  ‘6-K’ on / for 3/23/20   ·   Next:  ‘6-K’ on / for 4/2/20   ·   Latest:  ‘6-K’ on / for 3/14/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/30/20  AC Immune SA                      6-K         3/30/20    4:604K                                   Davis Polk & … LLP 01/FA

Current Report by a Foreign Issuer   —   Form 6-K   —   Rule 13a-16 / 15d-16
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Current Report by a Foreign Issuer                  HTML     11K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     61K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML    108K 
 4: EX-99.3     Miscellaneous Exhibit                               HTML     91K 


‘6-K’   —   Current Report by a Foreign Issuer


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of March, 2020

 

 

  

Commission File Number: 001-37891

 

AC IMMUNE SA

(Exact name of registrant as specified in its charter)

 

EPFL Innovation Park

Building B

1015 Lausanne, Switzerland

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F

  Form 40-F ☐ 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes  ☐   No

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes  ☐   No

 C: 

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  AC IMMUNE SA
   
  By: /s/ Andrea Pfeifer
    Name: Andrea Pfeifer
    Title: Chief Executive Officer

 

 

      By: /s/ Joerg Hornstein
        Name: Joerg Hornstein
        Title: Chief Financial Officer
Date: March 30, 2020        
 C: 

 C: 

 

Exhibit Index

 

Exhibit Number

Description

99.1 Press Release dated March 30, 2020
99.2 2019 Statutory Annual Report
99.3 2019 Compensation Report

 C: 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘6-K’ Filing    Date    Other Filings
Filed on / For Period end:3/30/2020-F
 List all Filings 
Top
Filing Submission 0000950103-20-006220   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 8:17:16.1am ET